Key facts
- This page summarizes Chang Liu's Form 3 filing for Curanex Pharmaceuticals Inc.
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 02 Sep 2025, 20:30.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
These shares of common stock are held directly by Korovyev Hippo LLC, an entity in which the Reporting Person has the sole voting and investment power. By virtue of this relationship, the Reporting Person may be deemed to have the sole beneficial ownership of the securities held of record by Korovyev Hippo LLC.
Footnote F2
These shares of common stock are held directly by Liu and Company LLC, an entity in which the Reporting Person has the sole voting and investment power. By virtue of this relationship, the Reporting Person may be deemed to have the sole beneficial ownership of the securities held of record by Liu and Company LLC.